Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in New-Onset Type 1 Diabetes: A Multicenter Analysis
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Type 1 diabetes (T1D) is one of the major autoimmune diseases affecting children and young adults worldwide. To date, the different immunotherapies tested have achieved insulin independence in <5% of treated individuals. Recently, a novel hematopoietic stem cell (HSC)–based strategy has been tested in individuals with new-onset T1D. The aim of this study was to determine the effects of autologous nonmyeloablative HSC transplantation in 65 individuals with new-onset T1D who were enrolled in two Chinese centers and one Polish center, pooled, and followed up for 48 months. A total of 59% of individuals with T1D achieved insulin independence within the first 6 months after receiving conditioning immunosuppression therapy (with antithymocyte globulin and cyclophosphamide) and a single infusion of autologous HSCs, and 32% remained insulin independent at the last time point of their follow-up. All treated subjects showed a decrease in HbA1c levels and an increase in C-peptide levels compared with pretreatment. Despite a complete immune system recovery (i.e., leukocyte count) after treatment, 52% of treated individuals experienced adverse effects. Our study suggests the following: 1) that remission of T1D is possible by combining HSC transplantation and immunosuppression; 2) that autologous nonmyeloablative HSC transplantation represents an effective treatment for selected individuals with T1D; and 3) that safer HSC-based therapeutic options are required.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“one study reported severe infections in T1D patients after the stem cell therapy.319,322–324”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [322]
In the citing paper
“However, there have been inconsistencies with these findings generated in other studies”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [322]
Citations
Cites
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., & Soltész, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60568-7 · Cited by 1,854
Orban, T., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Gottlieb, P. A., Greenbaum, C. J., Marks, J. B., Monzavi, R., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60886-6 · Cited by 612
Voltarelli, J. C., Couri, C. E. B., Stracieri, A. B. P. L., Oliveira, M. C., Moraes, D. A., Pieroni, F., Coutinho, M., Malmegrim, K. C. R., Foss-Freitas, M. C., Simões, B. P., et al. (2007) · JAMA · doi:10.1001/jama.297.14.1568 · Cited by 573 · cited 1×
“(10) succeeded in exploiting hematopoietic stem cells (HSCs) to treat new-onset T1D and achieved encouraging results, paving the way for another three trials, which were initiated worldwide (11,12).”
Sherry, N., Hagopian, W., Ludvigsson, J., Jain, S. M., Wahlen, J., Ferry, R. J., Bode, B., Aronoff, S., Holland, C., Carlin, D., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60931-8 · Cited by 493
Shah, S. C., Malone, J., & Simpson, N. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200902 · Cited by 317
Type 1 diabetes: translating mechanistic observations into effective clinical outcomes
Herold, K. C., Vignali, D. A. A., Cooke, A., & Bluestone, J. A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3422 · Cited by 237
The Clinical Impact of Islet Transplantation
Fiorina, P., Shapiro, A. M. J., Ricordi, C., & Secchi, A. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02353.x · Cited by 224
Self-citationRachamim, N., Gan, J., Segall, H., Krauthgamer, R., Marcus, H., Berrebi, A., Martelli, M., & Reisner, Y. (1998) · Transplantation · doi:10.1097/00007890-199805270-00017 · Cited by 180
Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans
Fadini, G. P., Albiero, M., Vigili de Kreutzenberg, S., Boscaro, E., Cappellari, R., Marescotti, M., Poncina, N., Agostini, C., & Avogaro, A. (2013) · Diabetes Care · doi:10.2337/dc12-1084 · Cited by 177
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Song, Y., Li, J., & Wu, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01952-8 · Cited by 259
Palchaudhuri, R., Saez, B., Hoggatt, J., Schajnovitz, A., Sykes, D. B., Tate, T. A., Czechowicz, A., Kfoury, Y., Ruchika, F., Rossi, D. J., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3584 · Cited by 217
Minimally Invasive and Regenerative Therapeutics
Ashammakhi, N., Ahadian, S., Darabi, M. A., El Tahchi, M., Lee, J., Suthiwanich, K., Sheikhi, A., Dokmeci, M. R., Oklu, R., & Khademhosseini, A. (2019) · Advanced Materials · doi:10.1002/adma.201804041 · Cited by 190
Cai, J., Wu, Z., Xu, X., Liao, L., Chen, J., Huang, L., Wu, W., Luo, F., Wu, C., Pugliese, A., et al. (2016) · Diabetes Care · doi:10.2337/dc15-0171 · Cited by 182
Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis
El-Badawy, A., & El-Badri, N. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151938 · Cited by 137
Nasr, M. B., Tezza, S., D’Addio, F., Mameli, C., Usuelli, V., Maestroni, A., Corradi, D., Belletti, S., Albarello, L., Becchi, G., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7543 · Cited by 142
Self-citationEngineering immunomodulatory biomaterials for type 1 diabetes
Stabler, C. L., Li, Y., Stewart, J. M., & Keselowsky, B. G. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0112-5 · Cited by 125
Malmegrim, K. C. R., de Azevedo, J. T. C., Arruda, L. C. M., Abreu, J. R. F., Couri, C. E. B., de Oliveira, G. L. V., Palma, P. V. B., Scortegagna, G. T., Stracieri, A. B. P. L., Moraes, D. A., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00167 · Cited by 119
Potential Clinical Applications of Stem Cells in Regenerative Medicine
Suman, S., Domingues, A., Ratajczak, J., & Ratajczak, M. Z. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-31206-0_1 · Cited by 110
Yeh, W.-I., Seay, H. R., Newby, B. N., Posgai, A. L., Moniz, F. B., Michels, A. W., Mathews, C. E., Bluestone, J. A., & Brusko, T. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01313 · Cited by 112
Hierlmeier, S. A., Eyrich, M. K., Wölfl, M., Schlegel, P., & Wiegering, V. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204914 · Cited by 97
Fadini, G. P., Ciciliot, S., & Albiero, M. (2016) · Stem Cells · doi:10.1002/stem.2445 · Cited by 97
Prevention and Reversal of Type 1 Diabetes—Past Challenges and Future Opportunities
Skyler, J. S. (2015) · Diabetes Care · doi:10.2337/dc15-0349 · Cited by 85
Gitelman, S. E., Gottlieb, P. A., Felner, E. I., Willi, S. M., Fisher, L. K., Moran, A., Gottschalk, M., Moore, W. V., Pinckney, A., Keyes-Elstein, L., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-3917-4 · Cited by 90
Engineered PD‐L1‐Expressing Platelets Reverse New‐Onset Type 1 Diabetes
Zhang, X., Kang, Y., Wang, J., Yan, J., Chen, Q., Cheng, H., Huang, P., & Gu, Z. (2020) · Advanced Materials · doi:10.1002/adma.201907692 · Cited by 91
Fadini, G. P., Rigato, M., Cappellari, R., Bonora, B. M., & Avogaro, A. (2017) · Diabetes Care · doi:10.2337/dc16-1755 · Cited by 86
Yazhen, Z., Wenyi, C., Bing, F., & Hongcui, C. (2020) · Aging and disease · doi:10.14336/ad.2019.0421 · Cited by 82
Seay, H. R., Putnam, A. L., Cserny, J., Posgai, A. L., Rosenau, E. H., Wingard, J. R., Girard, K. F., Kraus, M., Lares, A., Brown, H. L. G., et al. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2016.12.003 · Cited by 75
Haller, M. J., Gitelman, S. E., Gottlieb, P. A., Michels, A. W., Perry, D. J., Schultz, A. R., Hulme, M. A., Shuster, J. J., Zou, B., Wasserfall, C. H., et al. (2016) · Diabetes · doi:10.2337/db16-0823 · Cited by 70
Wan, X.-X., Zhang, D.-Y., Khan, M. A., Zheng, S.-Y., Hu, X., Zhāng, Q., Yang, R., & Xiong, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.859638 · Cited by 76
The rise, fall, and resurgence of immunotherapy in type 1 diabetes
Nasr, M. B., D’Addio, F., Usuelli, V., Tezza, S., Abdi, R., & Fiorina, P. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.07.004 · Cited by 71
Self-citationLü, J., Shen, S., Ling, Q., Wang, B., Li, L., Zhang, W., Qu, D., Bi, Y., & Zhu, D. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02417-3 · Cited by 70
Self-citationStem cell-derived exosomes: a novel vector for tissue repair and diabetic therapy
Newton, W. C., Kim, J. W., Luo, J. Z. Q., & Luo, L. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0080 · Cited by 64
Raikwar, S. P., Kim, E.-M., Sivitz, W. I., Allamargot, C., Thedens, D. R., & Zavazava, N. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116582 · Cited by 57
Snarski, E., Milczarczyk, A., Hałaburda, K., Torosian, T., Paluszewska, M., Urbanowska, E., Król, M., Boguradzki, P., Jedynasty, K., Franek, E., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.294 · Cited by 56
Self-citationArruda, L. C. M., Clave, E., Moins‐Teisserenc, H., Douay, C., Farge, D., & Toubert, A. (2016) · Current Research in Translational Medicine · doi:10.1016/j.retram.2016.03.004 · Cited by 57
Type 1 Diabetes and Dysfunctional Intestinal Homeostasis
D’Addio, F., & Fiorina, P. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.04.005 · Cited by 49
Self-citationSaha, A., Hyzy, S. L., Lamothe, T. L., Hammond, K. J., Clark, N., Lanieri, L., Bhattarai, P. R., Palchaudhuri, R., Gillard, G. O., Proctor, J., et al. (2022) · Blood · doi:10.1182/blood.2021012366 · Cited by 49
Cell therapy for type 1 diabetes
Loretelli, C., Assi, E., Seelam, A. J., Nasr, M. B., & Fiorina, P. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1748596 · Cited by 53
Self-citationSchreiner, F., Plamper, M., Düker, G., Schönberger, S., Gámez-Díaz, L. Y., Grimbacher, B., Hilger, A. C., Gohlke, B. C., Reutter, H. M., & Woelfle, J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3382 · Cited by 45
Immune Mechanisms and Pathways Targeted in Type 1 Diabetes
Jacobsen, L. M., Newby, B. N., Perry, D. J., Posgai, A. L., Haller, M. J., & Brusko, T. M. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1066-5 · Cited by 45
Combination immunotherapy for type 1 diabetes
Bone, R. N., & Evans-Molina, C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0878-z · Cited by 41
Kelsey, P., Oliveira, M. C., Badoglio, M., Sharrack, B., Farge, D., & Snowden, J. A. (2016) · Current Research in Translational Medicine · doi:10.1016/j.retram.2016.03.003 · Cited by 42
Cantú-Rodríguez, O. G., Lavalle-González, F., Herrera-Rojas, M. Á., Jaime-Pérez, J. C., Hawing-Zárate, J. Á., Gutiérrez-Aguirre, C. H., Mancias-Guerra, C., González-Llano, O., Zapata-Garrido, A., Villarreal-Pérez, J. Z., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2776 · Cited by 39
Re-engineering islet cell transplantation
Fotino, N., Fotino, C., & Pileggi, A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.02.010 · Cited by 43
Immunotherapy for type 1 diabetes
Frumento, D., Nasr, M. B., Essawy, B. E., D’Addio, F., Zuccotti, G., & Fiorina, P. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0641-y · Cited by 40
Self-citationMesenchymal stem cells to treat type 1 diabetes
Pixley, J. S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.033 · Cited by 40
T Cell Receptor Profiling in Type 1 Diabetes
Jacobsen, L. M., Posgai, A. L., Seay, H. R., Haller, M. J., & Brusko, T. M. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0946-4 · Cited by 42
Meta-analysis shows that mesenchymal stem cell therapy can be a possible treatment for diabetes
Habiba, U. E., Khan, N., Greene, D. L., Ahmad, K., Shamim, S., & Umer, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1380443 · Cited by 42
Clinical benefits of autologous haematopoietic stem cell transplantation in type 1 diabetes patients
Gu, B., Miao, H., Zhang, J., Hu, J., Zhou, W., Gu, W., Wang, W., & Ning, G. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.12.006 · Cited by 40
Self-citationTherapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
Liu, J., Ting, J. P., Al-Azzam, S., Ding, Y., & Afshar, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062805 · Cited by 40
Explaining the increased mortality in type 1 diabetes
Mameli, C., Mazzantini, S., Nasr, M. B., Fiorina, P., Scaramuzza, A. E., & Zuccotti, G. V. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i7.889 · Cited by 42
D’Addio, F., Trevisani, A., Nasr, M. B., Bassi, R., Essawy, B. E., Abdi, R., Secchi, A., & Fiorina, P. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0603-1 · Cited by 37
Self-citationLi, H., Zhu, H., Ge, T., Wang, Z., & Zhang, C. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10139-5 · Cited by 37
Wang, Z.-X., Cao, J., Li, D., Zhang, X.-Y., Liu, J., Li, J., Wang, M., Liu, Y., Xu, B., & Wang, H. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.02.014 · Cited by 36
Sun, Z., Gou, W., Kim, D., Dong, X., Strange, C., Tan, Y. J., Adams, D. B., & Wang, H. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.06.016 · Cited by 34
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy
Monfrini, M., Donzelli, E., Rodriguez‐Menendez, V., Ballarini, E., Carozzi, V., Chiorazzi, A., Meregalli, C., Canta, A., Oggioni, N., Crippa, L., et al. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.11.006 · Cited by 33
Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
Rathod, S. (2022) · Diabetology · doi:10.3390/diabetology3010007 · Cited by 40
Human urine-derived stem cells play a novel role in the treatment of STZ-induced diabetic mice
Zhao, T., Luo, D., Sun, Y. W., Niu, X., Wang, Y., Wang, C., & Jia, W. (2018) · Journal of Molecular Histology · doi:10.1007/s10735-018-9772-5 · Cited by 31
Diabetes mellitus as a poor mobilizer condition
Fadini, G. P., & DiPersio, J. F. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.11.002 · Cited by 34
Rahim, F., Arjmand, B., Shirbandi, K., Payab, M., & Larijani, B. (2018) · Non-coding RNA Investigation · doi:10.21037/sci.2018.11.01 · Cited by 30
Stem cells to restore insulin production and cure diabetes
Sordi, V., Pellegrini, S., Krampera, M., Marchetti, P., Pessina, A., Ciardelli, G., Fadini, G. P., Pintus, C., Pantè, G., & Piemonti, L. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.02.004 · Cited by 31
Research trends of stem cells in ischemic stroke from 1999 to 2018: A bibliometric analysis
Yang, C., Wang, X., Tang, X., Bao, X., & Wang, R. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.105740 · Cited by 31
Targeting Immunity in End-Stage Renal Disease
Baragetti, I., Essawy, B. E., & Fiorina, P. (2017) · American Journal of Nephrology · doi:10.1159/000458768 · Cited by 29
Self-citationNew Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes
Cabello-Olmo, M., Araña, M., Radichev, I., Smith, P., Huarte, E., & Barajas, M. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194789 · Cited by 29
Diabetes type 1: Can it be treated as an autoimmune disorder?
Vallianou, N. G., Stratigou, T., Geladari, E. V., Tessier, C. M., Mantzoros, C. S., & Dalamaga, Μ. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09642-4 · Cited by 35
Immunomodulation effect of mesenchymal stem cells in islet transplantation
Shrestha, M., Nguyen, T. T., Park, J., Choi, J. U., Yook, S., & Jeong, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112042 · Cited by 28
Pérez‐Basterrechea, M., Esteban, M. M., Álvarez‐Viejo, M., Fontanil, T., Cal, S., Pitiot, M. S., Otero, J., & Obaya, Á. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180695 · Cited by 28
Zeher, M., Papp, G., Nakken, B., & Szodoray, P. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.05.020 · Cited by 27
Novel immunological strategies for islet transplantation
Tezza, S., Nasr, M. B., Vergani, A., Valderrama-Vasquez, A., Maestroni, A., Abdi, R., Secchi, A., & Fiorina, P. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.06.016 · Cited by 25
Self-citationHematopoietic Stem Cells in Type 1 Diabetes
Pastore, I., Assi, E., Nasr, M. B., Bolla, A. M., Maestroni, A., Usuelli, V., Loretelli, C., Seelam, A. J., Abdelsalam, A., Zuccotti, G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.694118 · Cited by 24
Self-citationMa, X., Fang, C., Yan, J., Zhao, Q., & Tu, Y. (2018) · Talanta · doi:10.1016/j.talanta.2018.04.052 · Cited by 23
Madani, S., Amanzadi, M., Aghayan, H. R., Setudeh, A., Rezaei, N., Rouhifard, M., & Larijani, B. A. (2022) · Systematic Reviews · doi:10.1186/s13643-022-01950-3 · Cited by 27
Chen, T., Liou, S.-Y., Lin, H., Hung, M.-Y., Lin, C., Lin, Y., Lin, K., Padma, V. V., Yao, C., Kuo, W., et al. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1614631 · Cited by 21
Clinical efficacy of stem-cell therapy on diabetes mellitus: A systematic review and meta-analysis
Pires, I. G. S., Souza, J. A. S. E., Bisneto, A. V. D. M., Passos, X. S., & Carneiro, C. C. (2022) · Transplant Immunology · doi:10.1016/j.trim.2022.101740 · Cited by 19
Tang, S., Zhang, M., Zeng, S., Huang, Y., Qin, M., Nasri, U., Santamaría, P., Riggs, A. D., Jin, L., & Zeng, D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012389117 · Cited by 21
Hamad, F. R. B., Rahat, N., Shankar, K., & Tsouklidis, N. (2021) · Cureus · doi:10.7759/cureus.13563 · Cited by 26
Immunotherapies for prevention and treatment of type 1 diabetes
Jeun, R. (2025) · Immunotherapy · doi:10.1080/1750743x.2025.2473311 · Cited by 21
Innovative immunotherapies and emerging treatments in type 1 diabetes management
Zarei, M., Sheikholeslami, M. A., Mozaffari, M., & Mortada, Y. (2024) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2024.100247 · Cited by 23
Nasr, M. B., D’Addio, F., Malvandi, A. M., Faravelli, S., Castillo‐Leon, E., Usuelli, V., Rocchio, F., Letizia, T., Essawy, A. B. E., Assi, E., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01387 · Cited by 17
Self-citationGan, J., Wang, Y., & Zhou, X. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6769 · Cited by 20
A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
van Megen, K. M., Wout, E.-J. T. V. ’., Forman, S. J., & Roep, B. O. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00690 · Cited by 17
Challenges and Opportunities for Biomarkers of Clinical Response to AHSCT in Autoimmunity
Harris, K. M., Lü, T., Lim, N., & Turka, L. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00100 · Cited by 15
Disease modifying therapies in type 1 diabetes: Where have we been, and where are we going?
Lord, S. M., & Greenbaum, C. J. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.02.002 · Cited by 16
Advances in Immunotherapeutic Approaches to Type 1 Diabetes
Cudini, A., & Fierabracci, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119220 · Cited by 18
Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 Diabetes
Creusot, R. J., Battaglia, M., Roncarolo, M., & Fathman, C. G. (2016) · Stem Cells · doi:10.1002/stem.2290 · Cited by 15
Advances in hematopoietic stem cell transplantation for autoimmune diseases
Xu, Y., Wang, X., Hu, Z., Huang, R., Yang, G., Wang, R., Yang, S., Guo, L., Song, Q., Wei, J., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39302 · Cited by 14
Sionov, R. V., & Ahdut-HaCohen, R. (2023) · Biomedicines · doi:10.3390/biomedicines11092558 · Cited by 13
Xu, X., Yu, H., Sun, L., Zheng, C., Shan, Y., Zhou, Z., Wang, C., & Chen, B. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.10995 · Cited by 17
Nanotechnology in Immunotherapy for Type 1 Diabetes: Promising Innovations and Future Advances
Nigam, S., Bishop, J. O., Hayat, H., Quadri, T., Hayat, H., & Wang, P. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030644 · Cited by 16
Status of stem cells in diabetic nephropathy: predictive and preventive potentials
Baban, B., Liu, J. Y., Payne, S., Abebe, W., Yu, J. C.-K., & Mozaffari, M. S. (2016) · The EPMA Journal · doi:10.1186/s13167-016-0070-6 · Cited by 13
Stem Cell Research Tools in Human Metabolic Disorders: An Overview
Ricci, S., & Cacialli, P. (2021) · Cells · doi:10.3390/cells10102681 · Cited by 12
Li, C. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106304 · Cited by 12
The use of Hematopoietic Stem Cells in Autoimmune Diseases
Nasr, M. B., Bassi, R., Usuelli, V., Valderrama-Vasquez, A., Tezza, S., D’Addio, F., & Fiorina, P. (2016) · Regenerative Medicine · doi:10.2217/rme-2015-0057 · Cited by 13
Self-citationSnarski, E., Szmurło, D., Hałaburda, K., Król, M., Urbanowska, E., Milczarczyk, A., Franek, E., & Wiktor-Jędrzejczak, W. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0724-1 · Cited by 12
Self-citationAdvances in Regulatory Cell Therapy for Type 1 Diabetes: Emerging Strategies and Future Directions
Passerini, L., Forlani, A., & Gregori, S. (2025) · European Journal of Immunology · doi:10.1002/eji.202451722 · Cited by 14
Wu, Q., Zheng, S., Yao, Q., Zheng, X., Chen, H., Yang, T., & Zhang, M. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0050 · Cited by 13
Translation of cell therapies to treat autoimmune disorders
Mehta, J. M., Hiremath, S. C., Chilimba, C., Ghasemi, A., & Weaver, J. D. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115161 · Cited by 11
Meng, Y., Ji, J., Tan, W., Guo, G., Xia, Y., Cheng, C., Gu, Z., & Wang, Z. (2016) · Cell Biochemistry and Function · doi:10.1002/cbf.3161 · Cited by 11
Immune therapy in type 1 diabetes mellitus — Attempts to untie the Gordian knot?
Perakakis, N., & Mantzoros, C. S. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.016 · Cited by 10
Xiang, H., Chen, H., Li, F., Liu, J., Su, Y., Hao, L., Wang, F., Wang, Z., & Zeng, Q. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.07.006 · Cited by 10
Modern clinical management helps reducing the impact of type 1 diabetes in children
Scaramuzza, A. E., & Zuccotti, G. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.001 · Cited by 9
Zoso, A., Serafini, P., Lanzoni, G., Peixoto, E. M. L., Messinger, S., Mantero, A. M. A., Padilla, N., Baidal, D. A., Alejandro, R., Ricordi, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157245 · Cited by 10
Mania induced by high content caffeinated energy drinks.
Cruzado, L., Sánchez-Fernández, M., Cortez-Vergara, C. P., & Rojas-Rojas, G. (2014) · Actas Españolas de Psiquiatría · Cited by 15
Goenka, V., Borkar, T., Desai, A., & Das, R. K. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00647-5 · Cited by 10
Madani, S., Larijani, B. A., Keshtkar, A., & Tootee, A. (2018) · Systematic Reviews · doi:10.1186/s13643-017-0662-9 · Cited by 9
Yang, S.-F., Xue, W., Lu, W.-H., Xie, L., Yin, A.-P., Zheng, J., Sun, J.-P., & Li, Y. (2015) · Transplant Immunology · doi:10.1016/j.trim.2015.08.004 · Cited by 8
Carulli, E., Pompilio, G., & Vinci, M. C. (2023) · Cells · doi:10.3390/cells12071054 · Cited by 8
China’s Stem Cell Research and Knowledge Levels of Medical Practitioners and Students
Luo, D., Xu, Z., Wang, Z., & Ran, W. (2021) · Stem Cells International · doi:10.1155/2021/6667743 · Cited by 8
Metadata
- Authors
- D’Addio, F., Valderrama Vasquez, A., Ben Nasr, M., Franek, E., Zhu, D., Li, L., Ning, G., Snarski, E., & Fiorina, P.
- Affiliations
- Boston Children's Hospital (US)
- Transplant Medicine, IRCCS San Raffaele Hospital, Milan, Italy
- Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA
- Ministry of Interior and Administration (PL)
- Nanjing Drum Tower Hospital (CN)
- Shanghai Jiao Tong University (CN)
- Medical University of Warsaw (PL)
- Corresponding author
- Fiorina, Paolo
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-08-16
- Volume
- 63
- Issue
- 9
- Pages
- 3041-3046
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2147402097
- Cited by
- 160
- References
- 26
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 11 · 2023: 6 · 2022: 13 · 2021: 21 · 2020: 13 · 2019: 4 · 2018: 18 · 2017: 17 · 2016: 24 · 2015: 19 · 2014: 4
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- type 1 diabetes, autologous stem cell transplantation, nonmyeloablative conditioning, antithymocyte globulin, cyclophosphamide, insulin independence, remission, C-peptide, HbA1c, immune reconstitution, adverse effects
- MeSH terms
- Adolescent, Adult, C-Peptide, Child, Cyclophosphamide, Diabetes Mellitus, Type 1, Female, Humans, Immunosuppression Therapy, Insulin, Male, Remission Induction, Transplantation, Autologous, Hematopoietic Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.